Postpartum blood loss Postpartum haemorrhage Need for additional uterotonic drugs Need for blood transfusion Changes in hemoglobin level after delivery Side effects Blood loss,
Conditions
Interventions
combination of oxytocin 20 IU diluted in 1 l in 5%D/N/2 intravenous drip infusion of 120 ml/h and ergometrine 0.2 mg (1ml) intravenous injection,oxytocin 20 IU diluted in 1 l in 5%D/N/2 intravenous d
Active Comparator Drug,Placebo Comparator Drug
oxytocin 20 IU IV drip infusion of 120 ml/h and ergometrine 0.2 mg IV,oxytocin 20 IU IV drip infusion of 120 ml/h and NSS 1 ml IV
Sponsors
Vajira Institutional Review Board
Vajira Institutional Review Board
Eligibility
Sex/Gender
Female
Age
13 Years to 45 Years
Inclusion criteria
Inclusion criteria: singleton pregnancy at >28 weeks of gestation, cephalic presentation, anticipating a normal spontaneous vaginal delivery
Exclusion criteria
Exclusion criteria: non -cephalic presentation, multiple pregnancies, polyhydramnios, uterine fibroids, previous postpartum hemorrhage, antepartum hemorrhage, parity greater than four, previous cesarean section, severe anemia (hemoglobin level of ≤ 8 g/dL), coagulopathy, contraindications to the use of ergometrine, estimated fetal birth weight >4000 g, inability to obtain written consent, cesarean section, instrumental delivery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postpartum blood loss postpartum blood collection (ml) | — |
Secondary
| Measure | Time frame |
|---|---|
| PPH, side effect ,need for additional uterotonic drugs need for blood transfusion Changes in hemogl postpartum N | — |
Countries
Thailand
Contacts
Public ContactThitipun Nuamsiri
Vajira hospital
Outcome results
None listed